Workflow
Genesco(GCO)
icon
Search documents
Genesco(GCO) - 2022 Q1 - Earnings Call Transcript
2021-05-27 19:07
Genesco Inc. (NYSE:GCO) Q1 2022 Earnings Conference Call May 27, 2021 8:30 AM ET Company Participants Dave Slater - Vice President of FP&A & Investor Relations Mimi Vaughn - President & Chief Executive Officer Thomas George - Chief Financial Officer Conference Call Participants Steve Marotta - CL King Jonathan Komp - Baird Operator Good day, everyone, and welcome to the Genesco First Quarter Fiscal 2022 Conference Call. Just a reminder, today's call is being recorded. I will now turn the call over to Dave S ...
Genesco(GCO) - 2021 Q3 - Quarterly Report
2020-12-10 15:56
Part I. Financial Information This section presents the company's unaudited financial statements, management's discussion, market risk, and internal controls [Item 1. Financial Statements (unaudited)](index=4&type=section&id=Item%201.%20Financial%20Statements%20%28unaudited%29) This section presents unaudited condensed consolidated financial statements, including balance sheets, income, cash flows, equity, and notes on accounting policies, COVID-19, and segment performance [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) | Metric | Oct 31, 2020 (in thousands) | Feb 1, 2020 (in thousands) | Nov 2, 2019 (in thousands) | | :----- | :-------------------------- | :------------------------- | :------------------------- | | Total Assets | $1,536,500 | $1,680,478 | $1,785,492 | | Total Liabilities | $1,066,528 | $1,061,135 | $1,212,044 | | Total Equity | $469,972 | $619,343 | $573,448 | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) | Metric | 3 Months Ended Oct 31, 2020 (in thousands) | 3 Months Ended Nov 2, 2019 (in thousands) | 9 Months Ended Oct 31, 2020 (in thousands) | 9 Months Ended Nov 2, 2019 (in thousands) | | :----- | :----------------------------------------- | :---------------------------------------- | :----------------------------------------- | :---------------------------------------- | | Net sales | $479,280 | $537,263 | $1,149,729 | $1,519,487 | | Gross margin | $225,504 | $264,202 | $512,648 | $745,643 | | Operating income (loss) | $8,184 | $25,943 | $(169,828) | $37,989 | | Net Earnings (Loss) | $7,466 | $18,899 | $(146,347) | $25,822 | | Diluted EPS | $0.52 | $1.30 | $(10.31) | $1.60 | [Condensed Consolidated Statements of Comprehensive Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) | Metric | 3 Months Ended Oct 31, 2020 (in thousands) | 3 Months Ended Nov 2, 2019 (in thousands) | 9 Months Ended Oct 31, 2020 (in thousands) | 9 Months Ended Nov 2, 2019 (in thousands) | | :----- | :----------------------------------------- | :---------------------------------------- | :----------------------------------------- | :---------------------------------------- | | Net earnings (loss) | $7,466 | $18,899 | $(146,347) | $25,822 | | Total other comprehensive income (loss) | $(440) | $8,599 | $(8,332) | $(1,620) | | Comprehensive income (loss) | $7,026 | $27,498 | $(154,679) | $24,202 | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) | Metric | 9 Months Ended Oct 31, 2020 (in thousands) | 9 Months Ended Nov 2, 2019 (in thousands) | | :----- | :----------------------------------------- | :---------------------------------------- | | Net cash provided by operating activities | $51,302 | $2,806 | | Net cash provided by (used in) investing activities | $(18,132) | $77,342 | | Net cash used in financing activities | $(1,757) | $(191,318) | | Net increase (decrease) in cash and cash equivalents | $33,643 | $(111,529) | | Cash and cash equivalents at end of period | $115,061 | $55,826 | [Condensed Consolidated Statements of Equity](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Equity) | Metric | Balance Feb 1, 2020 (in thousands) | Balance Oct 31, 2020 (in thousands) | | :----- | :--------------------------------- | :---------------------------------- | | Total Equity | $619,343 | $469,972 | | Retained Earnings | $378,572 | $231,001 | | Accumulated Other Comprehensive Loss | $(31,668) | $(40,000) | [Notes to Condensed Consolidated Financial Statements (unaudited)](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements%20%28unaudited%29) This section provides detailed notes on the company's accounting policies, the impact of COVID-19, asset impairments, debt, and segment performance [Note 1 Summary of Significant Accounting Policies](index=9&type=section&id=Note%201%20Summary%20of%20Significant%20Accounting%20Policies) This note outlines the basis of presentation for the unaudited financial statements, describes the company's operations, and details key accounting policies - Genesco Inc. operates **1,476 retail stores** across the U.S., Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland, under banners such as Journeys, Journeys Kidz, Little Burgundy, Johnston & Murphy, and Schuh, in addition to e-commerce and wholesale operations[21](index=21&type=chunk) - The company's four reportable business segments are Journeys Group, Schuh Group, Johnston & Murphy Group, and Licensed Brands[22](index=22&type=chunk) - Adopted ASU No. 2018-13 (fair value measurement disclosure) and ASU No. 2016-13 (credit losses) in the first quarter of Fiscal 2021, with no material impact on the Condensed Consolidated Financial Statements[31](index=31&type=chunk)[32](index=32&type=chunk) [Note 2 COVID-19](index=12&type=section&id=Note%202%20COVID-19) This note details the significant operational and financial impacts of the COVID-19 pandemic, including store closures, revenue reductions, asset impairments, and government relief benefits - Temporary store closures and reduced customer traffic due to COVID-19 resulted in material reductions in revenues and operating income during the first three quarters of Fiscal 2021[33](index=33&type=chunk)[34](index=34&type=chunk) - Recorded a **$79.3 million goodwill impairment charge** for Schuh Group and a **$5.3 million trademark impairment charge** in the first quarter of Fiscal 2021 due to the impact of COVID-19[35](index=35&type=chunk) - Qualified payroll tax credits from the CARES Act and other foreign governmental packages reduced selling and administrative expenses by approximately **$7.0 million (Q1)**, **$3.8 million (Q2)**, and **$1.8 million (Q3)** in Fiscal 2021; UK government programs provided property tax relief of approximately **$1.6 million (Q1)**, **$3.9 million (Q2)**, and **$3.9 million (Q3)** in Fiscal 2021[38](index=38&type=chunk) - Recorded additional valuation allowance adjustments of **$2.0 million** in the UK jurisdiction in Q1 Fiscal 2021 due to anticipated losses, and excluded the UK tax jurisdiction from the annual effective tax rate estimate for Fiscal 2021[39](index=39&type=chunk) [Note 3 Goodwill and Other Intangible Assets](index=16&type=section&id=Note%203%20Goodwill%20and%20Other%20Intangible%20Assets) This note details changes in goodwill and other intangible assets, reporting a full impairment of Schuh Group's goodwill and a trademark impairment in Q1 FY21 due to COVID-19 - Goodwill attributed to Schuh Group was fully impaired, resulting in a **$79.3 million charge** in the first quarter of Fiscal 2021, due to qualitative indicators of impairment including a significant decline in stock price and market capitalization from the COVID-19 pandemic[41](index=41&type=chunk) - Recorded a trademark impairment of **$5.3 million** in the first quarter of Fiscal 2021, affecting Journeys Group and Johnston & Murphy Group, based on a royalty savings approach[45](index=45&type=chunk) | Metric | February 1, 2020 (in thousands) | October 31, 2020 (in thousands) | | :----- | :------------------------------ | :------------------------------ | | Total Goodwill | $122,184 | $38,129 | [Note 4 Asset Impairments and Other Charges](index=18&type=section&id=Note%204%20Asset%20Impairments%20and%20Other%20Charges) This note reports pretax charges for retail store asset impairments, totaling $6.4 million in Q3 FY21 and $16.0 million for the first nine months of Fiscal 2021 - Recorded pretax charges of **$6.4 million** in the third quarter of Fiscal 2021 for retail store asset impairments[49](index=49&type=chunk) - Recorded pretax charges of **$16.0 million** in the first nine months of Fiscal 2021, including **$5.3 million** for trademark impairment and **$11.1 million** for retail store asset impairments, partially offset by a **$(0.4) million** gain from the Togast acquisition earnout release[49](index=49&type=chunk) [Note 5 Inventories](index=18&type=section&id=Note
Genesco(GCO) - 2021 Q3 - Earnings Call Transcript
2020-12-04 17:31
Genesco Inc. (NYSE:GCO) Q3 2021 Earnings Conference Call December 4, 2020 8:30 AM ET Company Participants Dave Slater - VP of FP&A & Investor Relations Mimi Vaughn - President & Chief Executive Officer Conference Call Participants Steve Marotta - CL King Janine Stichter - Jefferies Jonathan Komp - Baird Sam Poser - Susquehanna Mitch Kummetz - Pivotal Research Operator Good day, everyone, and welcome to the Genesco’s Third Quarter Fiscal 2021 Conference Call. Just a reminder, today's call is being recorded. ...
Genesco(GCO) - 2021 Q2 - Quarterly Report
2020-09-10 16:29
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended August 1, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File No. 1-3083 Genesco Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |------------------------------|-- ...
Genesco(GCO) - 2021 Q2 - Earnings Call Transcript
2020-09-03 15:09
Genesco Inc. (NYSE:GCO) Q2 2021 Earnings Conference Call September 3, 2020 8:30 AM ET Company Participants David Slater - Vice President of Financial Planning & Analysis & Investor Relations Mimi Vaughn - Board Chair, President & Chief Executive Officer Mel Tucker - Chief Financial Officer Conference Call Participants Janine Stichter - Jefferies Jonathan Komp - Robert W. Baird Mitch Kummetz - Pivotal Research Sam Poser - Susquehanna Operator Good day, everyone, and welcome to the Genesco Second Quarter Fisc ...
Genesco(GCO) - 2021 Q1 - Quarterly Report
2020-06-11 13:34
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended May 2, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File No. 1-3083 Genesco Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |------------------------------|----- ...
Genesco(GCO) - 2021 Q1 - Earnings Call Transcript
2020-06-09 16:09
Genesco Inc. (NYSE:GCO) Q1 2021 Earnings Conference Call June 9, 2020 8:30 AM ET Company Participants Dave Slater - VP FP&A & IR Mimi Vaughn - President & CEO Mel Tucker - CFO Conference Call Participants Steve Marotta - CL King & Associates Janine Stichter - Jefferies Mitch Kummetz - Pivotal Research Sam Poser - Susquehanna Jonathan Komp - Baird Operator Good day, everyone and welcome to the Genesco First Quarter Fiscal 2021 Conference Call. Just as a reminder, today's call is being recorded. I would now l ...